Stephen Franks

Title: The Innovations of Stephen Franks

Introduction

Stephen Franks is a notable inventor based in London, GB. He has made significant contributions to the field of medicine, particularly in the treatment of anovulatory women. With a total of 2 patents, his work focuses on the use of gonadotrophins to induce folliculogenesis.

Latest Patents

Franks' latest patents include innovative methods for using gonadotrophins in the treatment of anovulatory women. The first patent discusses the use of luteinizing hormone (LH) or an equivalent dosage of human chorionic gonadotropin (hCG) in the production of a medicament aimed at inducing folliculogenesis. This invention specifies daily doses and highlights the potential use of LH in conjunction with follicle-stimulating hormone (FSH). The second patent reiterates this approach, emphasizing the importance of gonadotrophins in facilitating folliculogenesis in women who do not ovulate.

Career Highlights

Throughout his career, Stephen Franks has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Merck Serono S.A. and Applied Research Systems Ars Holding N.V. His experience in these organizations has contributed to his expertise in reproductive health and hormonal treatments.

Collaborations

Franks has collaborated with various professionals in his field, including Stephen Hillier. Their joint efforts have further advanced the understanding and application of gonadotrophins in medical treatments.

Conclusion

Stephen Franks is a distinguished inventor whose work has significantly impacted the treatment of anovulatory women. His innovative patents and collaborations reflect his commitment to advancing reproductive health.